Physiopathology and prognosis of diabetic foot
DOI:
https://doi.org/10.1016/j.rccot.2015.04.006Keywords:
diabetic foot, polyneuropathy, necrosis, thioctic acid, pregabalinAbstract
The reflections that are made in this paper respond to the increase of this disease in the community. The considerations about it from its initial diagnosis are minimal, and it seems that as time passes, increases its prevalence in the community. Sequels that diabetic foot produces are devastating for the patient from the standpoint of medical complications, quality of life, social behavior, work behavior and great financial costs when these complications occur.
Therefore, according to previous studies, we get to know the damage caused by diabetes in the foot, and the development of the pathophysiology of them. This review is presented with the aim of reaching a presence each increasing in university bodies and NGOs in order to promote the establishment of public health programs for the management of this condition.
Downloads
References
Rosas Guzmán J, Odriozola A, Davidson JA, eds. Guía práctica en el manejo de la polineuropatía diabética Neuralad 2010.
Kahn CR, Weir GC, et al. Jodlin's Diabetes Mellitus;. Philadelphia: Lea & Fabiger; 1994. p. 300.
Pedraza L. Neurólogo Dolor neuropático. Diagnóstico Univ. Chile.
Manual Merck, 8.a edición. Barcelona: Doyma, 1989.
Gagliardino JJ. Evaluations of quality of diabetes care in Latin America. Rev Panam Salud Publica. 2001;10(5). https://doi.org/10.1590/S1020-49892001001100003
Costa Gil JE. XII Congreso Argentino de Diabetes; octubre 2002.
Olivera EM. Revista de la Sociedad Argentina de Diabetes 1992;26:41-51.
Boulton AJM. The diabetic foot: grand overview, epidemiology and pathogenesis. Diabetes Metab Res Ver. 2008;24 Suppl 1:S3-6. https://doi.org/10.1002/dmrr.833
Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293:217-28. https://doi.org/10.1001/jama.293.2.217
Brownlee M. The pathobiology of diabetic complications. Diabetes. 2005;54:1615-25. https://doi.org/10.2337/diabetes.54.6.1615
Boulton AJM, Armstrong D, Albert S, Fryberg R, Hellman R, Kirkman M, et al. ADA-AACE Task Force. Diabetes Care. 2008;31 Suppl 1:1679-85. https://doi.org/10.2337/dc08-9021
Triana R. Recomendaciones de manejo de pié diabético. Simposio sobre Pie Diabético, marzo 23-24/2012, Cali.
Martínez-De Jesús FR. A checklist system to score healing progress of diabetic foot ulcers. Int J Low Extrem Wounds. 2010;9:74. https://doi.org/10.1177/1534734610371594
Sergeev IN, Rhoten WB. 1,25-Dihydroxyvitamin D3 evokes oscillations of intracellular calcium in a pancreatic b-cell line. Endocrinology. 1995;136:2852-61. https://doi.org/10.1210/endo.136.7.7789310
Boucher BJ. Inadequate vitamin D status: does it contribute to the disorders comprising syndrome X. Br J Nutr. 1998;79:315-27. https://doi.org/10.1079/BJN19980055
Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract. 2003;57:258-61. https://doi.org/10.1111/j.1742-1241.2003.tb10480.x
Lind L, Heanni A, Litthell H, Hvarfner A, Seorensen OH, Ljunghall S. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens. 1995;8:894-901. https://doi.org/10.1016/0895-7061(95)00154-H
Inomata S, Kadowaki S, Yamatani T, Fukase M, Fujita T. Effect of 1 alfa (OH)-vitamnin D3 on insulin secretion in diabetes mellitus. Bone Miner. 1986;1:187-92.
Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr. 2003;89:552-72. https://doi.org/10.1079/BJN2003837
Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care. 2007;30:980-6.
Rev Med Chile 2010; 138: 1312-1318. Vitamina D y síndrome metabólico - M. I. Querales et al., 1318 Artículo de Revisión. https://doi.org/10.2337/dc06-1994
Mattila C, Knekt P, Männistö S, Rissanen H, Laaksonen MA, Montonen J, et al. Serum 25-Hydroxyvitamin D concentration subsequent risk of Type 2 diabetes. Diabetes Care. 2007;30:2569-70. https://doi.org/10.2337/dc07-0292
Di Cesar DJ, Ploutz-Snyder R, Weinstock RS, Moses AM. Vitamin D deficiency is more common in type 2 than in type 1 diabetes. Diabetes Care. 2006;29:174. https://doi.org/10.2337/diacare.29.01.06.dc05-1876
Becker B, Hullet D, O'Herrin J, Malin G, Sollinger H, DeLuca H. Vitamin D as immunomodulatory therapy for kidney transplantation. Transplantation. 2002;74:1204-6. https://doi.org/10.1097/00007890-200210270-00030
Lemire J, Archer D, Beck L, Spiegelber H. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr. 1995;125:1704S-8S. https://doi.org/10.1016/0960-0760(95)00106-A
Long K, Santos J. Vitamins and the regulation of the immune response. Pediatr Infect Dis J. 1999;18:283-90. https://doi.org/10.1097/00006454-199903000-00018
Adorini L. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes. Ann NY Acad Sci. 2003;987:258-61. https://doi.org/10.1111/j.1749-6632.2003.tb06057.x
Rigby W, Waugh M, Graziano R. Regulation of human monocyte HLA-DR and CD4 antigen expression, and antigen presentation by 1,25-dihidroxyvitamin D3. Blood. 1990;76:189-97. https://doi.org/10.1182/blood.V76.1.189.189
Zella J, DeLuca H. Vitamin D autoimmune diabetes. J Cell Biochem. 2003;88:216-22. https://doi.org/10.1002/jcb.10347
Bian K, Ishibashi K, Bukoski R. 1,25(OH)2D3 modulates intracellular Ca+2 and force generation in resistance arteries. Am J Physiol. 1996;270:H230-7. https://doi.org/10.1152/ajpheart.1996.270.1.H230
Krause R, Buhring M, Hopfenmuller W, Holick M, Sharma A. Ultraviolet B and blood pressure. Lancet. 1998;352:709-10. https://doi.org/10.1016/S0140-6736(05)60827-6
Li Y, Kong J, Wei M, Chen Z, Liu S, Cao L. 1,25-dihydroxyvitamin D3 is a negative endocrine regulator of rennin-angiotensin system. J Clin Invest. 2002;110:229-38. https://doi.org/10.1172/JCI0215219
Xiang W, Kong J, Chen S, Cao L, Qiao G, Zheng W, et al. Cardiac hypertrophy in vitamin D receptor Knockout mice: role of the systemic and cardiac rennin-angiotensin systems. Am J Physiol Endocrinol Metab. 2005;228:E125-32. https://doi.org/10.1152/ajpendo.00224.2004
Jespersen B, Randlow A, Abrahamsen J, Fogh-Andersen N, Olsen N, Kanstrup I. Acute cardiovascular effect of 1,25- dihydroxycholecalciferol in essential hypertension. Am J Hypertens. 1998;11:659-66. https://doi.org/10.1016/S0895-7061(98)00025-9
Hatton D, Xue H, DeMerritt H, McCarron D. 1,25-(OH)2 Vitamin D3-induced alterations in vascular reactivity in the spontaneously hypertensive rats. Am J Med Sci. 1995;269:C443-50.
Pereira M, Jacobs D, Van Horn L, Slattery M, Kartashov A, Ludwig D. Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA study. JAMA. 2002;287:2081-9. https://doi.org/10.1001/jama.287.16.2081
Fujita T, Palmieri G. Calcium Paradox disease: calcium deficiency prompting secondary hyperparathyroidism and cellular calcium overload. J Bone Miner Metab. 2000;18:109-25. https://doi.org/10.1007/s007740050101
Zemel M, Shi H, Greer B, Dirienzo D, Zemel P. Regulation of adiposity by dietary calcium. FASEB J. 2000;14:1132-8. https://doi.org/10.1096/fasebj.14.9.1132
Melanson E, Sharp T, Schneider J, Donahoo W, Grunwald G, Hill J. Relation between calcium intake and fat oxidation in adult humans. Int J Obes Relat Metab Disord. 2003;77:1448-52. https://doi.org/10.1038/sj.ijo.802202
Wehmeir K, Beers A, Haas M, et al. Inhibition of AI gene expression by 1,25-dihydroxyvitamin D3. Biochim Biophys Acta. 2005;1737:16-26. https://doi.org/10.1016/j.bbalip.2005.09.004
Ford E, Ajani U, McGuire L, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care. 2005;28:1228-30. https://doi.org/10.2337/diacare.28.5.1228
Reis J, von Mühlen D, Kritz-Silverstein D, Wingard D, Barrett-Connor E. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care. 2007;30: 1549-55. https://doi.org/10.2337/dc06-2438
Hjelmesaeth J, HofsØ D, Aasheim ET, Jenssen T, Moan J, Hager H, et al. Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovascular Diabetology. 2009;8:7. https://doi.org/10.1186/1475-2840-8-7
Liu S, Song Y, Ford E, Manson J, Buring J, Ridker P. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care. 2005;28:2926-32. https://doi.org/10.2337/diacare.28.12.2926
Oliveri MB, Ladizesky M, Mautalen CA, Alonso A, Martínez L. Seasonal variations of hydroxyvitamin D and parathyroid hormone in Ushuaia (Argentina), the southern most city of the world. Bone Miner. 1993;20:99-108. https://doi.org/10.1016/S0169-6009(08)80041-4
Bunout D, Barrera G, Leiva L, Gattas V, de la Maza MP, Haschke F, et al. Effect of a nutritional supplementation on bone health in Chilean elderly subjects with femoral osteoporosis. J Am Coll Nutr. 2006;25:170-7. https://doi.org/10.1080/07315724.2006.10719529
De la Maza MP, Leiva L, Barrera G, Boggiano C, Herrera T, Pérez Y, et al. Evaluación a largo plazo del estado nutricional, composición corporal y densidad mineral ósea en mujeres operadas de bypass gástrico: impacto del nivel socioeconómico. Rev Med Chile. 2008;136:1415-23. https://doi.org/10.4067/S0034-98872008001100007
Pinilla AE, Fonseca GC. Pie diabético. En: Ardila E, Arteaga JM, Rueda PN, editores. Perspectivas en medicina interna. Bogotá: Unibiblos; 2000.
Armstrong DG, Lavery LA. Clinical Care of Diabetes foot. ADA. 2005:1-10.
Lobmann R, Schultz G, Lehnert H. Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications. Diabetes Care. 2005;28:461-71. https://doi.org/10.2337/diacare.28.2.461
Márquez G, Escobar I, Brugués J, eds. Análisis del grupo colombiano de Colpedis para el pie diabético. Federación Diabetológica Colombiana, Guías para prevención, Diagnóstico y Tratamiento, 2007.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Revista Colombiana de ortopedia y traumatología
This work is licensed under a Creative Commons Attribution 3.0 Unported License.
